TRABD
TraB domain-containing protein
Also known as: PP2447, TRABD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H4I3
- Gene
- TRABD
- Ensembl
- ENSG00000170638
- Chromosome
- 22
- Canonical length
- 376 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Enables mitochondrion-mitochondrion outer membrane tether activity. Involved in mitochondrial fusion. Located in mitochondrion. Is active in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q9H4I3|TRABD
1 MDGEEQQPPH EANVEPVVPS EASEPVPRVL SGDPQNLSDV DAFNLLLEMK LKRRRQRPNL
61 PRTVTQLVAE DGSRVYVVGT AHFSDDSKRD VVKTIREVQP DVVVVELCQY RVSMLKMDES
121 TLLREAQELS LEKLQQAVRQ NGLMSGLMQM LLLKVSAHIT EQLGMAPGGE FREAFKEASK
181 VPFCKFHLGD RPIPVTFKRA IAALSFWQKV RLAWGLCFLS DPISKDDVER CKQKDLLEQM
241 MAEMIGEFPD LHRTIVSERD VYLTYMLRQA ARRLELPRAS DAEPRKCVPS VVVGVVGMGH
301 VPGIEKNWST DLNIQEIMTV PPPSVSGRVS RLAVKAAFFG LLGYSLYWMG RRTASLVLSL
361 PAAQYCLQRV TEARHKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRABD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 72 nTPM
- bone marrow: 58 nTPM
- esophagus: 40 nTPM
- liver: 40 nTPM
- spleen: 37 nTPM
- lymph node: 31 nTPM
Single-cell type
- esophageal apical cells: 198 nCPM
- pdcs: 135 nCPM
- plasma cells: 113 nCPM
- neutrophil progenitors: 109 nCPM
- esophageal suprabasal cells: 100 nCPM
- breast lactating cells: 100 nCPM
Immune cell
- plasmacytoid DC: 69 nTPM
- eosinophil: 52 nTPM
- neutrophil: 41 nTPM
- myeloid DC: 33 nTPM
- NK-cell: 32 nTPM
- classical monocyte: 31 nTPM
Brain region
- cerebellum: 21 nTPM
- medulla oblongata: 18 nTPM
- cerebral cortex: 17 nTPM
- thalamus: 15 nTPM
- amygdala: 15 nTPM
- midbrain: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.93
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TraB/PrgY/GumN family
- TraB/PrgY/gumN family
- TraB/PryY-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRABD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRABD as an antibody target. Whether an autoantibody or antibody against TRABD could matter depends on whether native TRABD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRABD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRABD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...